SLIGHT HICCUP2 Mar 2019 13:57
From being in here for two years, it appears the issue responsible for devastating the SP is a hiccup, the product, ICLAPRIM, still has massive market potential , but any good news now, relating to an RNS stating approval is granted, moving from the current SP is a far cry from 38p prior to 14th, i personally think someone or some folk should come forward and explain how they have f----d up so badly ? accountability ! as it would appear they have, or why the point, regarding toxicity was only raised during the final analysis, baffling, people sat on large paper losses here, need some answers i feel. This should be £1 + now